Sunday, December 2, 2018

Link Between Gum Disease & Alzheimer's Disease

Periodontitis May Initiate Alzheimer’s Disease


Periodontitis May Initiate Alzheimer’s Disease
Long-term exposure to Porphyromonas gingivalis causes inflammation and degeneration of brain neurons in mice that is similar to the effects of Alzheimer’s disease in human beings, according to the University of Illinois at Chicago (UIC). These findings suggest that periodontal disease may be an initiator of Alzheimer’s disease, researchers there report. 
“Other studies have demonstrated a close association between periodontitis and cognitive impairment, but this is the first study to show that exposure to the periodontal bacteria results in the formation of senile plaques that accelerate the development of neuropathology found in Alzheimer’s patients,” said Keiko Watanabe, DDS, professor of periodontics at the UIC College of Dentistry and corresponding author of the study. 
“This was a big surprise,” Watanabe said. “We did not expect that the periodontal pathogen would have this much influence on the brain or that the effects would so thoroughly resemble Alzheimer’s disease.”
To study the impact of the bacteria on brain health, the researchers established chronic periodontitis in 10 wild-type mice. Another 10 mice served as the control group. After 22 weeks of repeated oral application of the bacteria to the study group, the researchers studied the brain tissue of the mice and compared brain health. 
The mice chronically exposed to the bacteria had significantly higher amounts of accumulated amyloid beta, a senile plaque found in the brain tissue of Alzheimer’s patients. The study group also had more brain inflammation and fewer intact neurons due to degeneration. 
These findings were further supported by amyloid beta protein analysis and RNA analysis that showed greater expression of genes associated with inflammation and degeneration in the study group. DNA from the periodontal bacteria was also found in the brain tissue of mice in the study group, and a bacterial protein was observed inside their neurons. 
“Our data not only demonstrate the movement of bacteria from the mouth to the brain, but also that chronic infection leads to neural effects similar to Alzheimer’s,” Watanabe said.
The researchers say these findings are powerful in part because they used a wild-type mouse model. Most model systems used to study Alzheimer’s rely on transgenic mice, which have been genetically altered to more strongly express genes associated with the senile plaque and enable Alzheimer’s development. 
“Using a wild-type mouse model added strength to our study because these mice were not primed to develop the disease, and use of this model gives additional weight to our findings that periodontal bacteria may kickstart the development of the Alzheimer’s,” Watanabe said. 
The researchers say that understanding causality and risk factors for the development of Alzheimer’s is critical to the development of treatments, particularly when it comes to sporadic or late-onset disease, which constitutes more than 95% of cases and has largely unknown causes and mechanisms. Watanabe also said the findings offer lessons for everyone.
“Oral hygiene is an important predictor of disease, including diseases that happen outside the mouth,” she said. “People can do so much more for their personal health by taking oral health seriously.” 

Saturday, August 11, 2018

E-Cigarettes Link to Increase Risk of Oral Cancer

E-Cigarettes Linked to Increased Risk of Oral Cancer

 02 Aug 2018  Dentistry Today 
 1978 times
E-Cigarettes Linked to Increased Risk of Oral Cancer
Tobacco remains a leading cause of oral cancer. But the market is evolving with increased usage of non-cigarette tobacco products, which often are touted as safer alternatives, and the dual use of multiple product types. So, researchers at the University of California San Francisco School of Dentistry and School of Medicine are evaluating exposure to known carcinogens according to recent use of different tobacco product types, alone or in combination.  
The researchers analyzed data from the Population Assessment of Tobacco and Health, which includes a sample of adults in the United States who provided urine specimens for analysis of tobacco-specific nitrosamines (TSNAs) N’-nitrosonornicotine (NNN), a known oral and esophageal carcinogen, 4-(methynitrosamino)-1-(3)-pyridyle-1-butanol (NNAL), a metabolite of lung carcinogen (NNK), and total nicotine equivalents.
Participants were categorized according to the use of combustible, which includes cigarettes, cigars, water pipes, pipes, blunts or marijuana-containing cigars, and smokeless, which includes moist snuff, chewing tobacco and snus, e-cigarettes, and nicotine replacement products. For each product, recent use was defined as within the previous three days, and non-use was defined as none within 30 days.
All tobacco use categories demonstrated elevated nicotine and TSNA concentrations relative to non-users. TSNA exposures were highest among smokeless tobacco users, whether used alone or together with other product types. Exclusive e-cigarette users were exposed to lower NNN and NNAL levels than other product users despite comparable nicotine exposure. However, most e-cigarette users concurrently used combustible tobacco resulting in TSNA exposure similar to exclusive cigarette smokers.
According to the researchers, most non-cigarette tobacco users in vast numbers are exposed to carcinogen levels comparable to or exceeding exposure among exclusive cigarette smokers, levels that are likely to place users at substantial risk. The researchers presented their study, “Nicotine and Carcinogen Exposure by Tobacco Product Type and Dual Use,” at last week’s 96th General Session of the International Association for Dental Research in London.

Sunday, April 1, 2018

BOTOX USE IN TREATMENT OF TMJ DISORDERS

BOTOX® Treatments for TMJ

American Academy of Facial Esthetics Trained Physicians, Dentists and Nurse


BOTOX® Treatment for Jaw Tension and TMJ

BOTOX® is used as an alternative treatment for TMJ (temporo-mandibular joint) disorders and associated jaw tension and pain. When injected into facial muscles afflicted with soreness and discomfort, BOTOX® relieves TMJ and jaw tension for many patients. The injections often eliminate headaches resulting from teeth grinding, and, in cases of severe stress, BOTOX® can even minimize lock jaw. Although BOTOX® treatment for these conditions is presently experimental; evidence indicates that it can be extremely effective.

How Does BOTOX® Treat Jaw Tension and TMJ Disorder?

Located on both sides of the head at the point where the jawbone meets the skull, the temporo-mandibular joint (TMJ) is used during talking, eating, swallowing, and other everyday activities. If this joint becomes displaced or is overworked through excessive teeth grinding, a person may suffer severe tension headaches, as well as sharp pain in the jaw. BOTOX® relieves jaw tension by making muscles unable to engage in the powerful, often unconscious movement of the jaw that produces headaches and pain.
The BOTOX® alternative treatment for TMJ disorders and jaw tension is usually quick, straightforward, and effective. A non-surgical procedure, BOTOX® injections are administered in a doctor’s office and treatment requires no hospital stay. Most patients experience noticeable improvement within one or two days of their first treatment, although relief can take up to a week.

Areas Affected by TMJ Botox Therapy

Only the areas injected with Botox will be “relaxed.” Botox treatment for TMJ therapy will not affect anywhere else in your body. The injections are mainly in the temporalis, frontalis and masseter (see picture below) additional sites may be injected with Botox depending on the severity of the headaches.

How long is the Botox Treatment Procedure?

The length of the Botox treatment procedure depends on the number of injections needed as determined by the doctor. Still, it is reasonable for the treatment procedure to be completed within 10-30 minutes.

Is the Botox Treatment Painful?

The pain associated with the Botox TMJ Treatment procedure is due to the injections, but it is generally minimal and brief. Some patients have likened the Botox injection pain unto a “bug bite” or “prick”. Pain from the injection can be reduced by numbing proposed injection sites with a cold pack or anesthetic cream. If you are scared of needles the doctor may offer you Happy Gas.

What to Expect After the Botox TMJ Treatment?

After the Botox TMJ Treatment muscle tenderness will start to disappear almost immediately. Wrinkles begin to disappear within 24 – 48 hours after the injections, and you may continue to see the wrinkles diminish up to one week after the Botox treatment procedure.
There may be mild temporary bruising, numbness, or redness around the injection sites. You will not look 20 years younger, but you may find that you look more natural and relaxed or less sad and angry. A small number of patients treated with Botox injections reported no noticeable difference in the reduction of their wrinkles.

What is the Recovery from Botox Therapy for TMJ Treatment Like?

Because the Botox Treatment procedure is non-surgical and non-invasive, it is highly likely that the patient can return to normal activities immediately. However, to avoid spreading the toxin to other muscles, patients should not rub or massage the area injected with Botox and remain upright for many hours. Physical activity should also be limited for a time.

Risks, Limitations & Possible Complications of Botox Injections for TMJ Treatment

As with any medical procedure there are possible risks and side effects when using Botox for TMJ treatment. Since this is a non-surgical treatment procedure, the risks and possible complications are infrequent, minimal and temporary.
The most common reported side-effects of Botox treatment are headaches, respiratory infection, flu syndrome, temporary eye-lid droop, and nausea. Less commonly reported effects of Botox are pain, redness at spot of injection, and muscle weakness. These symptoms are thought to be connected with the Botox injection and occur within the first week.
There could also be bruising at the injection site. The lips are used more than the forehead for common activities such as chewing, kissing, and talking. Therefore Botox injections around the mouth are less useful in TMJ treatment and can have more potential inconvenient effects. These every day activities may become more difficult and too much Botox® around the mouth can result in drooling. Another limitation to Botox® injection for TMJ treatments is that there is a possibility of developing antibodies that would render the TMJ treatments less and less effective over time. This resistance could be delayed by using the lowest effective dose possible over the longest intervals of time. Botox injection treatments should be avoided during pregnancy and lactation.
Disclaimer: botox, dysport, dermal fillers, facial injections, and other skin care information contained on this website is provided for educational purposes and should not be taken as medical advice. To consult with one of our AAFE trained members, please contact one of our trained members today.